During the past decade, Synexus Clinical Research GmbH conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 11 clinical trials were completed, i.e. on average, 84.6% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 6 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Synexus Clinical Research GmbH" #1 sponsor was "Pfizer" with 5 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Amgen" with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus Clinical Research GmbH" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "CoLucid Pharmaceuticals" with 1 trials as a collaborator and "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Synexus Clinical Research GmbH" are "Cardiovascular Disease" (2 trials), "Crohn's Disease" (2 trials), "Osteoarthritis" (2 trials), "Acute Pain" (1 trials) and "COVID-19 Prevention" (1 trials). Many other conditions were trialed in "Synexus Clinical Research GmbH" in a lesser frequency.

Most popular intervention types in "Synexus Clinical Research GmbH" are "Drug" (19 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Lasmiditan" (2 trials), "Mirikizumab" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Synexus Clinical Research GmbH" are 20 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Synexus Clinical Research GmbH". undefined are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Synexus Clinical Research GmbH, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Synexus Clinical Research GmbH, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".